These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2690090)

  • 1. Aluminum as a pathogenic factor in senile dementia of the Alzheimer type: ion specific chelation.
    Kruck TP; McLachlan DR
    Prog Clin Biol Res; 1989; 317():1155-67. PubMed ID: 2690090
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 3. Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum.
    McLachlan DR; Smith WL; Kruck TP
    Ther Drug Monit; 1993 Dec; 15(6):602-7. PubMed ID: 8122302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum: a possible neurotoxic agent in Alzheimer's disease.
    Crapper DR; Krishnan SS; De Boni U; Tomko GJ
    Trans Am Neurol Assoc; 1975; 100():154-6. PubMed ID: 1241624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etiopathogenetic concepts in senile dementia of the Alzheimer type].
    Fărcăşel L; Chiriac ME
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):493-5. PubMed ID: 3074434
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluminum and neurodegenerative disease: therapeutic implications.
    McLachlan DR; Kruck TP; VanBerkum MF
    Am J Kidney Dis; 1985 Nov; 6(5):322-9. PubMed ID: 2865894
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in human linker histone-DNA binding in the presence of aluminum salts in vitro and in Alzheimer's disease.
    Lukiw WJ; Kruck TP; McLachlan DR
    Neurotoxicology; 1987; 8(2):291-301. PubMed ID: 3601241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment.
    Huang Y; Savory J; Herman MM; Nicholson JR; Reyes MR; Boyd JC; Wills MR
    Neurotoxicology; 1995; 16(2):291-6. PubMed ID: 7566688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
    Warady BA; Ford DM; Gaston CE; Sedman AB; Huffer WE; Lum GM
    Pediatrics; 1986 Oct; 78(4):651-5. PubMed ID: 3763276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The silicon link between aluminium and Alzheimer's disease.
    Miu AC
    J Alzheimers Dis; 2006 Sep; 10(1):39-42. PubMed ID: 16988480
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin structure in Alzheimer's disease: effect on 5' leader sequence for NF-L gene and role of aluminum.
    McLachlan DR; Lukiw WJ; Mizzen CA; Kruck TP
    Prog Clin Biol Res; 1989; 317():1061-75. PubMed ID: 2690086
    [No Abstract]   [Full Text] [Related]  

  • 13. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE; Johnson CA
    Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and aluminum in Alzheimer's disease.
    Di Lorenzo F; Di Lorenzo B
    Neuro Endocrinol Lett; 2013; 34(6):504-7. PubMed ID: 24378455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
    Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT
    Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical and etiopathogenic aspects of senile Alzheimer-type dementia].
    Nicolini H; Ortega H; de la Fuente JR
    Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):343-8. PubMed ID: 3076315
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in trace elements during brain aging and in Alzheimer's dementia.
    Chazot G; Broussolle E
    Prog Clin Biol Res; 1993; 380():269-81. PubMed ID: 8456130
    [No Abstract]   [Full Text] [Related]  

  • 18. Amyloid, aluminium and the aetiology of Alzheimer's disease.
    Walton JR
    Med J Aust; 1996 Mar; 164(6):382-3. PubMed ID: 8606673
    [No Abstract]   [Full Text] [Related]  

  • 19. Metal chelation therapy for Alzheimer disease.
    Rosenberg RN
    Arch Neurol; 2003 Dec; 60(12):1678-9. PubMed ID: 14676040
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum-fluoride complexes: preclinical studies.
    Shore D; Sprague SM; Mayor GH; Moreno EC; Apostoles PS; Wyatt RJ
    J Environ Pathol Toxicol Oncol; 1985; 6(1):9-13. PubMed ID: 4067838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.